Colorectal Neoplasms - Diagnosis
Research News and Information

Sunday, November 22, 2009

Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer.

30 Oct 2009 Evaluation of pathologic predictors of metastases in T1 stage colorectal cancer may be difficult with hematoxylin and eosin (HE) staining alone. The aim of this study was to clarify the role of pathologic predictors by using immunohistochemical ... Read more...

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

22 Sep 2009 BACKGROUND: Although colorectal cancer screening is cost-effective, it requires a considerable net investment by governments or insurance companies. If screening was cost saving, governments and insurance companies might be more inclined to invest ... Read more...

Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme.

13 Sep 2009 BACKGROUND: The cutoff of semi-quantitative immunochemical faecal occult blood tests (iFOBTs) influences colonoscopy referrals and detection rates. We studied the performance of an iFOBT (OC-Sensor) in colorectal cancer (CRC) screening at different ... Read more...

Latest indexed articles for 'Colorectal Neoplasms - Diagnosis'

These are the very latest articles for this heading:

• Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer. 30 Oct 2009
• Capsule endoscopy versus colonoscopy. 13 Oct 2009
• Capsule endoscopy versus colonoscopy. 13 Oct 2009
• Computed tomographic colonography for detecting advanced neoplasia. 12 Oct 2009
• Computed tomographic colonography for detecting advanced neoplasia. 12 Oct 2009
• Plasma microRNAs: a potential biomarker for colorectal cancer? 29 Sep 2009
• Idiopathic gastric acid hypersecretion in a patient with MUTYH-associated polyposis. 29 Sep 2009
• Are split bowel preparation regimens practical for morning colonoscopies? Implications of the new american college of gastroenterology colon cancer screening guidelines for real-world clinical practice. 29 Sep 2009
• Colorectal cancer guidance is self-serving. 29 Sep 2009
• American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008. 29 Sep 2009
• Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. 22 Sep 2009
• Clinical practice. Screening for colorectal cancer. 15 Sep 2009
• Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. 13 Sep 2009
• Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications? 5 Sep 2009
• More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. 30 Aug 2009
• Bolus-tracking MRI with a simultaneous T1- and T2*-measurement. 30 Aug 2009
• Colon cancer screening and surveillance controversies. 30 Aug 2009
• Colorectal cancer testing in Canada--2008. 30 Aug 2009
• [Cancer genetics: estimation of the needs of the population in France for the next ten years] 30 Aug 2009
• MALDI-MS-NIST library approach for colorectal cancer diagnosis. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Colorectal Neoplasms'

Definition: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Descriptor UI: D015179

Alternative terms: Colorectal Neoplasms; Colorectal Tumors; Colorectal Tumor; Tumor, Colorectal; Tumors, Colorectal; Neoplasms, Colorectal; Colorectal Neoplasm; Neoplasm, Colorectal; Colorectal Carcinoma; Carcinoma, Colorectal; Carcinomas, Colorectal; Colorectal Carcinomas; Colorectal Cancer; Cancer, Colorectal; Cancers, Colorectal; Colorectal Cancers;

Related Mesh Headings: Genes, DCC; Genes, MCC;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.274.476.411.307; C06.301.371.411.307; C06.405.249.411.307; C06.405.469.158.356; C06.405.469.491.307; C06.405.469.860.180;

History Note: 89

Technical Notes: a clinical entity: not a synonym for COLONIC NEOPLASMS + RECTAL NEOPLASMS; coord IM with histol type of neopl (IM); GENES, DCC (for "Deleted in Colorectal Cancer") & GENES, MCC (for "Mutated in Colorectal Cancer") are available: see MeSH scope notes and annotations there